University Of Kansas Medical Center
Clinical trials sponsored by University Of Kansas Medical Center, explained in plain language.
-
Could a cancer drug put nerve disease into Long-Term remission?
Disease control TerminatedThis study aimed to test if rituximab, a drug that targets immune B cells, could help control Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a disorder where the immune system attacks the nerves. Researchers wanted to see if the drug could allow some patients to stop t…
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Zoom vs. doctor: rural weight loss showdown
Disease control OngoingThis study compares two telemedicine approaches to help rural residents with obesity manage their weight over 18 months. One approach uses quarterly doctor visits, while the other adds group lifestyle coaching sessions via Zoom. Researchers want to see which method helps people l…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New 'Smart Bomb' drug trial offers hope for Tough-to-Treat bile duct cancer
Disease control OngoingThis study is testing a drug called sacituzumab govitecan in people with advanced bile duct cancer (cholangiocarcinoma) that has come back or spread after at least one prior treatment. The drug is designed to target cancer cells specifically, delivering a toxic agent directly to …
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Could a Pre-Surgery sports drink cut complications?
Disease control OngoingThis study is testing if drinking a special carbohydrate drink before a long urologic surgery helps control blood sugar levels and leads to better recovery. It will compare a specialized sports drink to a standard one in 30 adults having surgery lasting over 4 hours. Researchers …
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug duo tested for Tough-to-Treat bile duct cancer
Disease control OngoingThis study is testing whether combining two drugs, regorafenib and durvalumab, can help control advanced bile duct cancer that has continued to grow after standard chemotherapy. It is for up to 40 patients whose cancer has worsened despite one prior treatment. The main goals are …
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
Blood pressure drug trial offers new hope for CF patients
Disease control OngoingThis small, early-stage study is testing whether losartan, a common blood pressure medication, can help improve mucus clearance in adults with cystic fibrosis who cannot take newer, targeted CFTR therapies. Researchers want to see if reducing inflammation with losartan for 14 wee…
Phase: EARLY_PHASE1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Can parents lead the way to healthier weight for rural kids?
Disease control OngoingThis study is testing a new approach to help rural families manage weight. It compares two versions of a televideo program: one where parents get coaching first, then join sessions with their child, versus a program where parents and children attend together from the start. The g…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Drug used in transplants could slow rare Muscle-Wasting disease
Disease control OngoingThis study is testing whether sirolimus, a medication used in organ transplants, can slow down or stop the progression of inclusion body myositis (IBM), a rare muscle-wasting disease. It will involve 140 adults with IBM who will take the drug or a placebo for 84 weeks to see if i…
Phase: PHASE3 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New drug duo tested in fight against advanced breast cancer
Disease control OngoingThis early-stage study is testing the safety of combining two drugs, alpelisib and sacituzumab govitecan, for people with advanced HER2-negative breast cancer that has spread or returned. The main goal is to find the safest and most effective dose of this combination for use in f…
Phase: PHASE1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New tracking tool aims to catch cervical cancer earlier in kenya
Prevention OngoingThis study is testing a web-based tracking system designed to help more women in Kenya get screened for cervical cancer and receive proper follow-up care if needed. It involves 10 hospitals and aims to see if the system improves how often women complete screening and get the righ…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Prevention
Last updated Apr 01, 2026 14:43 UTC
-
Program aims to close health gap for women after jail
Prevention OngoingThis study tests a health education program designed for women who are leaving jail. The program aims to improve their knowledge and actions related to preventing cervical cancer, breast cancer, sexually transmitted diseases, and unintended pregnancy. Researchers are comparing th…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Prevention
Last updated Mar 30, 2026 14:33 UTC
-
New hope for women at high risk of breast cancer?
Prevention OngoingThis study is testing whether a combination of two hormone medications (bazedoxifene and conjugated estrogens) can reduce markers of breast cancer risk in women who are at increased risk and experiencing menopausal hot flashes. About 120 women will be randomly assigned to take th…
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Prevention
Last updated Mar 17, 2026 13:09 UTC
-
Zap to the rescue? electrical stimulation tested for faster ACL recovery
Symptom relief ENROLLING_BY_INVITATIONThis study is testing if adding a special type of electrical muscle stimulation to standard physical therapy helps people recover muscle strength better after ACL knee surgery. Researchers will compare muscle strength and symmetry between the injured and healthy leg in about 25 p…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Freeze or burn? new study pits cold therapy against heat for back pain relief
Symptom relief ENROLLING_BY_INVITATIONThis study is comparing two procedures that target nerves to relieve chronic low back pain. It tests a newer method that freezes nerves (iovera°) against the standard method that uses heat to burn them (radiofrequency ablation). Researchers will enroll 30 people and track their p…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Mar 16, 2026 15:23 UTC
-
Could earlier catheter removal get back surgery patients walking faster?
Symptom relief TerminatedThis study aimed to find out if removing a patient's urinary catheter sooner after minimally invasive back surgery helps them get up and walk faster. It planned to compare 'early removal' to the usual 'delayed removal' timing. The goal was to see if walking sooner could lead to a…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Feb 23, 2026 14:56 UTC
-
Can your workout routine save your memory? scientists test Exercise's brain benefits
Knowledge-focused OngoingThis study aims to understand how different types of exercise affect memory and brain health in older adults. Researchers will enroll 280 healthy adults aged 65-80 and assign them to different 26-week exercise programs, including aerobic training, strength training, or a combinat…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Could a common blood pressure pill also ease chronic pain?
Knowledge-focused OngoingThis study aims to understand if lowering blood pressure can help manage chronic pain. It involves 36 adults who have both chronic back pain and high blood pressure, and who already have a permanent spinal cord stimulator. Participants will take a standard blood pressure pill (a …
Phase: EARLY_PHASE1 • Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Why your statin might block your workout gains
Knowledge-focused OngoingThis study aims to understand why some people taking cholesterol-lowering statin drugs don't improve their fitness as much from exercise as expected. Researchers will have a small group of statin users complete a 6-week supervised exercise program. They will measure fitness befor…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC
-
Could a weight loss shot lower breast cancer risk?
Knowledge-focused OngoingThis study is checking if the weight loss medication tirzepatide changes markers in the body that are linked to breast cancer risk. It involves 20 women with obesity who are already planning to take tirzepatide. Researchers will measure things in their blood, breast tissue, and s…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC